Safety study of cultured human Wharton’s Jelly mesenchymal stem cell therapy for multiple indications – a retrospective descriptive study

Safety study of cultured human Wharton’s Jelly mesenchymal stem cell therapy for multiple indications – a retrospective descriptive study

OBJECTIVE: Human umbilical cord Wharton’s Jelly derived MSCs (WJ-MSCs) are reported as the most potent cell source of mesenchymal stem cells, however they remain understudied in comparison to autologous sources. This study aimed to evaluate the safety of WJ-MSC therapy for a range of conditions and...

Full description

Bibliographic Details
Main Authors: B. Mehling, D. Wu, D. Santora, E. O’Gorman, K. Novakova, G. Spencer, C. Thomas, R. Grant, R. Rutherford, R. Mihályová
Format: Article
Language:English
Published: Verduci Editore 2022-10-01
Series:CellR4
Subjects:
cell therapy
mesenchymal stem cells (mscs)
regenerative medicine
wharton’s jelly mesenchymal stem cells
Online Access:https://www.cellr4.org/wp-content/uploads/sites/2/2022/10/e3332.pdf

Internet

https://www.cellr4.org/wp-content/uploads/sites/2/2022/10/e3332.pdf

Similar Items